Echo Street Capital Management LLC Gilead Sciences, Inc. Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $324,596 - $354,141	4,390 New	4,390 $328,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $599,925 - $683,500	7,760 Added 162.41%	12,538 $1.04 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $297,764 - $427,487	4,778 New	4,778 $410,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $787,647 - $887,126	-13,646 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $790,376 - $990,426	13,646 New	13,646 $811,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $386,640 - $441,156	-6,444 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $365,052 - $415,960	6,444 New	6,444 $375,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.